{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative adjective directly modifies a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15980", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment details a vaccine deal and options using factual language, lacking high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_19372", "batch_size": 200, "batch_pos": 4, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "'secures' is not a moderate verb. 'doses' is not impact/harm scale.", "method": "llm_batch", "batch_id": "batch_3_19136", "batch_size": 200, "batch_pos": 135, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_15280", "batch_size": 200, "batch_pos": 125, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports details of vaccine deal but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17816", "batch_size": 200, "batch_pos": 122, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"hop_idx": 6, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_6_11752", "batch_size": 200, "batch_pos": 97, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser token combined with a scale contrast for reassurance.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_6_11752_r1", "batch_size": 200, "batch_pos": 97, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment describes a deal and does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_14220", "batch_size": 200, "batch_pos": 87, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing vaccine doses (a preparedness measure/capability) without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_12612", "batch_size": 200, "batch_pos": 163, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
